These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 6202835)

  • 1. Effect of N-acetyl-muramyl-L-alanyl-D-isoglutamine on interferon production in mice by Newcastle disease virus.
    Sakuma T; Azuma M; Yoshida I
    J Gen Virol; 1984 May; 65 ( Pt 5)():999-1003. PubMed ID: 6202835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon-stimulating activity of muramoyl dipeptide glycosides].
    Zholobak NM; Spivak NIa; Zemliakov AE; Tsikalov VV; Chupakhina TA; Kur'ianov VO; Chirva VIa
    Mikrobiol Z; 2007; 69(4):33-9. PubMed ID: 17977450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I; Fidler IJ
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
    Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
    Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
    Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
    J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro regulation by muramyl dipeptide of interferon production from peripheral blood mononuclear cells of healthy volunteers.
    Al-Attiyah RJ; Bahr GM; Strannegard O; Chedid L; Behbehani K
    Int J Immunopharmacol; 1988; 10(8):931-8. PubMed ID: 2463973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
    Geetha B; Sodhi A
    Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D; Jeannin JF; Lagadec P; Martin F
    J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by muramyldipeptides of the activities of early-type inducers of interferon.
    Ikeda S; Matsuda Y; Nishimura C
    Antiviral Res; 1985 Dec; 5(6):345-53. PubMed ID: 2418780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
    Dewhirst FE
    Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice.
    Cheadle WG; Ausobsky JR; Trachtenberg LS; Lamont P; Polk HC
    Am Surg; 1986 Nov; 52(11):613-7. PubMed ID: 3535600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked enhancement of macrophage activation induced by synthetic muramyl dipeptide (MDP) conjugate using monoclonal anti-MDP antibodies.
    Leclerc C; Bahr GM; Chedid L
    Cell Immunol; 1984 Jul; 86(2):269-77. PubMed ID: 6733783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro immune response to sheep erythrocytes in macrophage depleted cultures. Restoration with interleukine 1 or a monokine from resident macrophages and stimulation by N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
    Souvannavong V; Rimsky L; Adam A
    Biochem Biophys Res Commun; 1983 Jul; 114(2):721-8. PubMed ID: 6603843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
    Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of interferon induction in spleen and adherent peritoneal cells of mice by the lipophilic antiviral muramyl peptide MTP-PE.
    Meyer T; Dietrich FM; Walker MR; Hochkeppel HK
    J Interferon Res; 1986 Jun; 6(3):183-8. PubMed ID: 2427620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.